TNFSF12-TNFSF13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.858300E-02
Normal-vs-Stage2
6.638400E-01
Normal-vs-Stage3
4.800800E-01
Normal-vs-Stage4
1.933820E-01
Stage1-vs-Stage2
3.760500E-02
Stage1-vs-Stage3
1.258760E-01
Stage1-vs-Stage4
2.903800E-01
Stage2-vs-Stage3
6.853800E-01
Stage2-vs-Stage4
3.180400E-01
Stage3-vs-Stage4
5.222200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.510000E-01
Normal-vs-AfricanAmerican
2.483600E-01
Normal-vs-Asian
5.962200E-01
Caucasian-vs-AfricanAmerican
4.908400E-01
Caucasian-vs-Asian
7.729200E-01
AfricanAmerican-vs-Asian
7.393800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.136600E-01
Normal-vs-Female
7.072800E-01
Male-vs-Female
3.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.234200E-01
Normal-vs-Age(41-60Yrs)
3.577400E-01
Normal-vs-Age(61-80Yrs)
5.550400E-01
Normal-vs-Age(81-100Yrs)
8.523000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.116000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.057200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.219200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.957800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.520600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.291600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.974600E-01
Normal-vs-Daily Drinker
8.652200E-01
Normal-vs-Weekly Drinker
5.337400E-01
Normal-vs-Occasional Drinker
1.066980E-01
Normal-vs-Social Drinker
5.146400E-01
Non Drinker-vs-Daily Drinker
6.885400E-01
Non Drinker-vs-Weekly Drinker
3.256500E-02
Non Drinker-vs-Occasional Drinker
1.073180E-01
Non Drinker-vs-Social Drinker
8.175200E-01
Daily Drinker-vs-Weekly Drinker
2.507400E-01
Daily Drinker-vs-Occasional Drinker
1.246610E-01
Daily Drinker-vs-Social Drinker
5.873000E-01
Weekly Drinker-vs-Occasional Drinker
5.153900E-04
Weekly Drinker-vs-Social Drinker
3.596200E-02
Occasional Drinker-vs-Social Drinker
2.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.781000E-01
Normal-vs-Grade 2
6.738400E-01
Normal-vs-Grade 3
6.819200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.284400E-02
Grade 1-vs-Grade 3
3.929400E-01
Grade 1-vs-Grade 4
2.781000E-01
Grade 2-vs-Grade 3
4.313700E-02
Grade 2-vs-Grade 4
6.738400E-01
Grade 3-vs-Grade 4
6.819200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.164000E-01
Normal-vs-NonDiabetic
5.174800E-01
Diabetic-vs-NonDiabetic
5.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.781400E-01
Normal-vs-NoPancreatitis
5.728200E-01
Pancreatitis-vs-NoPancreatitis
3.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.601600E-01
Normal-vs-N1
6.809000E-01
N0-vs-N1
1.151050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.146800E-01
Normal-vs-TP53-NonMutant
1.391050E-01
TP53-Mutant-vs-TP53-NonMutant
2.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
